Savant Capital’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $400K | Buy |
+1,827
| New | +$400K | ﹤0.01% | 1213 |
|
|
2025
Q1 | – | Sell |
-1,003
| Closed | -$329K | – | 1659 |
|
|
2024
Q4 | $329K | Buy |
1,003
+131
| +15% | +$42.9K | ﹤0.01% | 1061 |
|
|
2024
Q3 | $262K | Buy |
872
+75
| +9% | +$22.5K | ﹤0.01% | 1152 |
|
|
2024
Q2 | $263K | Buy |
797
+99
| +14% | +$32.6K | ﹤0.01% | 1030 |
|
|
2024
Q1 | $276K | Sell |
698
-92
| -12% | -$36.4K | ﹤0.01% | 924 |
|
|
2023
Q4 | $278K | Sell |
790
-100
| -11% | -$35.2K | ﹤0.01% | 724 |
|
|
2023
Q3 | $334K | Buy |
890
+56
| +7% | +$21K | 0.01% | 623 |
|
|
2023
Q2 | $319K | Buy |
834
+167
| +25% | +$63.9K | 0.01% | 634 |
|
|
2023
Q1 | $231K | Buy |
+667
| New | +$231K | ﹤0.01% | 649 |
|
|
2022
Q3 | – | Sell |
-810
| Closed | -$245K | – | 575 |
|
|
2022
Q2 | $245K | Buy |
+810
| New | +$245K | 0.01% | 475 |
|